Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.350
-0.020 (-1.46%)
Apr 29, 2026, 9:46 AM EDT - Market open
Cardiol Therapeutics Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 21.42 | 30.58 | 34.93 | 59.47 | 83.9 | Upgrade
|
| Cash & Short-Term Investments | 21.42 | 30.58 | 34.93 | 59.47 | 83.9 | Upgrade
|
| Cash Growth | -29.97% | -12.46% | -41.26% | -29.12% | 498.20% | Upgrade
|
| Accounts Receivable | - | - | - | - | 0.07 | Upgrade
|
| Other Receivables | 0.23 | 0.36 | 0.28 | 0.48 | 0.34 | Upgrade
|
| Receivables | 0.23 | 0.36 | 0.28 | 0.48 | 0.41 | Upgrade
|
| Prepaid Expenses | 1.86 | 0.73 | 0.94 | 1.49 | 2.83 | Upgrade
|
| Total Current Assets | 23.5 | 31.67 | 36.15 | 61.44 | 87.14 | Upgrade
|
| Property, Plant & Equipment | 0.12 | 0.2 | 0.34 | 0.3 | 0.36 | Upgrade
|
| Other Intangible Assets | - | - | 0.21 | 0.29 | 0.38 | Upgrade
|
| Total Assets | 23.62 | 31.86 | 36.7 | 62.03 | 87.88 | Upgrade
|
| Accounts Payable | 3.48 | 6.98 | 7.62 | 8.35 | 4.14 | Upgrade
|
| Accrued Expenses | - | - | 0.42 | 0.99 | 0.72 | Upgrade
|
| Current Portion of Leases | 0.04 | 0.03 | 0.02 | 0.05 | 0.04 | Upgrade
|
| Other Current Liabilities | 2.14 | - | 0.24 | 0.42 | 6.66 | Upgrade
|
| Total Current Liabilities | 5.66 | 7.01 | 8.3 | 9.8 | 11.57 | Upgrade
|
| Long-Term Leases | 0.09 | 0.13 | 0.16 | 0.02 | 0.07 | Upgrade
|
| Total Liabilities | 5.74 | 7.14 | 8.45 | 9.83 | 11.64 | Upgrade
|
| Common Stock | 201.87 | 179.34 | 148.52 | 147.55 | 142.92 | Upgrade
|
| Additional Paid-In Capital | 29.08 | 24.65 | 18.79 | 15.59 | 12.66 | Upgrade
|
| Retained Earnings | -213.07 | -179.25 | -142.58 | -114.45 | -83.52 | Upgrade
|
| Comprehensive Income & Other | - | - | 3.52 | 3.52 | 4.18 | Upgrade
|
| Shareholders' Equity | 17.88 | 24.73 | 28.25 | 52.2 | 76.24 | Upgrade
|
| Total Liabilities & Equity | 23.62 | 31.86 | 36.7 | 62.03 | 87.88 | Upgrade
|
| Total Debt | 0.13 | 0.16 | 0.17 | 0.07 | 0.12 | Upgrade
|
| Net Cash (Debt) | 21.29 | 30.42 | 34.76 | 59.4 | 83.78 | Upgrade
|
| Net Cash Growth | -30.01% | -12.47% | -41.48% | -29.10% | 504.11% | Upgrade
|
| Net Cash Per Share | 0.24 | 0.43 | 0.54 | 0.95 | 1.94 | Upgrade
|
| Filing Date Shares Outstanding | 111.87 | 82.61 | 68.27 | 64.1 | 61.93 | Upgrade
|
| Total Common Shares Outstanding | 100.26 | 82.61 | 65.35 | 64.04 | 61.92 | Upgrade
|
| Working Capital | 17.85 | 24.66 | 27.86 | 51.63 | 75.58 | Upgrade
|
| Book Value Per Share | 0.18 | 0.30 | 0.43 | 0.82 | 1.23 | Upgrade
|
| Tangible Book Value | 17.88 | 24.73 | 28.04 | 51.91 | 75.86 | Upgrade
|
| Tangible Book Value Per Share | 0.18 | 0.30 | 0.43 | 0.81 | 1.23 | Upgrade
|
| Machinery | 0.41 | 0.39 | 0.42 | 0.35 | 0.28 | Upgrade
|
| Leasehold Improvements | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.